Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress?-Reference-Cited by-同舟云学术

Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress?

Published:2007 Issue:3 Volume:110 Page:525-533
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bria Emilio,Milella Michele,Gelibter Alain,Cuppone Federica,Pino Maria Simona,Ruggeri Enzo Maria,Carlini Paolo,Nisticò Cecilia,Terzoli Edmondo,Cognetti Francesco,Giannarelli Diana

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference38 articles.

1. Cancer Statistics, 2006

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

3. Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

4. Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments;Frontiers in Oncology;2024-07-01

2. Survival benefits and safety of chemotherapy regimens for pancreatic cancer: An umbrella review of meta-analyses of randomized controlled trials;Annals of Pancreatic Disorders and Treatment;2022-06-03

3. A Critical Overview of Systematic Reviews of Chemotherapy for Advanced and Locally Advanced Pancreatic Cancer using both AMSTAR2 and ROBIS as Quality Assessment Tools;Reviews on Recent Clinical Trials;2021-05-07

4. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies;Biomedicines;2021-04-06

5. Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data;Frontiers in Oncology;2020-08-11